The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 17.24%.However, over the last six months, we can see a stronger performance of -13.29%. Over the last 30 days, the price of DNA has fallen by 5.48%. And in the last five days, it has surged by 3.29%.
At present, Ginkgo Bioworks Holdings Inc (DNA) has a stock price of $11.94. In the previous session, the stock saw a rise, peaking at $16.0 after an opening price of $11.94. The day’s lowest price was $6.0, and it closed at $13.8.
Ginkgo Bioworks Holdings Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $16.85 on 02/06/25 and a low of $5.00 for the same time frame on 04/04/25.
52-week price history of DNA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Ginkgo Bioworks Holdings Inc’s current trading price is -29.14% away from its 52-week high, while its distance from the 52-week low is 138.80%. The stock’s price range during this period has varied between$5.00 and $16.85. The Ginkgo Bioworks Holdings Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.83 million for the day, a figure considerably higher than their average daily volume of 1.51 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Ginkgo Bioworks Holdings Inc (DNA) has experienced a quarterly rise of 47.59% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 706.85M and boasts a workforce of 834 employees.
Ginkgo Bioworks Holdings Inc: Analysts’ Ratings Unveiled
As of right now, 1 analyst is rating Ginkgo Bioworks Holdings Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.28, with a change in price of +5.29. Similarly, Ginkgo Bioworks Holdings Inc recorded 1,450,426 in trading volume during the last 100 days, posting a change of +79.55%.
DNA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for DNA stands at 0.70. Similarly, the long-term debt-to-equity ratio is also 0.70.
DNA Stock Stochastic Average
As of today, Ginkgo Bioworks Holdings Inc’s raw stochastic average for the last 50 days stands at 54.90%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 13.02%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 42.64% and 52.18%, respectively.
